| Literature DB >> 31352823 |
Masahiro Koizumi1,2, Kohei Ueda3, Fumio Niimura4, Akira Nishiyama5, Motoko Yanagita6, Akihiko Saito7, Ira Pastan8, Toshiro Fujita3, Masafumi Fukagawa1, Taiji Matsusaka2,9.
Abstract
We have previously shown that podocyte injury increases the glomerular filtration of liver-derived Agt (angiotensinogen) and the generation of intrarenal Ang II (angiotensin II) and that the filtered Agt is reabsorbed by proximal tubules in a manner dependent on megalin. In the present study, we aimed to study the role of megalin in the generation of renal Ang II and sodium handling during nephrotic syndrome. We generated proximal tubule-specific megalin KO (knockout) mice and crossed these animals with NEP25 mice, in which podocyte-specific injury can be induced by injection of the immunotoxin LMB2. Without podocyte injury, renal Agt staining was markedly diminished and urinary Agt increased in KO mice. However, renal Ang II was similar between KO and control mice on average: 117 (95% CI, 101-134) versus 101 (95% CI, 68-133) fmol/g tissue. We next tested the effect of megalin KO on intrarenal Ang II generation with podocyte injury. Control NEP25 mice showed markedly increased renal Agt staining and renal Ang II levels: 450 (336-565) fmol/g tissue. Megalin KO/NEP25 mice showed markedly diminished Agt reabsorption and attenuated renal Ang II: 199 (156-242) fmol/g tissue (P<0.001). Compared with control NEP25 mice, megalin KO/NEP25 mice excreted 5-fold more sodium in the urine. Western blot analysis showed that megalin KO decreased NHE3 and the cleaved α and γ forms of Epithelial Na Channel. These data indicate that Agt reabsorbed by proximal tubules via megalin in nephrotic syndrome is converted to Ang II, which may contribute to sodium retention and edema formation by activating NHE3 and Epithelial Na Channel.Entities:
Keywords: angiotensin II; angiotensinogen; kidney diseases; low density lipoprotein receptor-related protein-2; nephrotic syndrome; podocyte
Mesh:
Substances:
Year: 2019 PMID: 31352823 PMCID: PMC8288562 DOI: 10.1161/HYPERTENSIONAHA.118.12352
Source DB: PubMed Journal: Hypertension ISSN: 0194-911X Impact factor: 10.190